Analyst Ratings

Upgrades, downgrades, and outlook changes from major analysts.

Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.

Articles

3,519 total articles

William Blair Sticks With Outperform on CBRE After Strong Quarter; Sector Peers May Benefit

William Blair Sticks With Outperform on CBRE After Strong Quarter; Sector Peers May Benefit

William Blair has reaffirmed an Outperform rating on CBRE Group following the company’s latest quarterly results, citing a across-the-board beat in transactional businesses and upbeat EPS guidance that points to momentum through 2027. The reiteration comes as CBRE retains a Buy consensus among analysts and shows solid near-term fundamentals despite…

Truist Keeps Hold Rating on ICON as Internal Probe Weighs on Shares

Truist Keeps Hold Rating on ICON as Internal Probe Weighs on Shares

Truist Securities has maintained a Hold rating and a $222.00 price target on ICON plc (ICLR) after the company disclosed an internal probe into its revenue recognition. Preliminary findings suggest modest overstatements for 2023 and 2024, and the review has prompted delays to the company’s fourth-quarter and full-year 2025 results and prompted seve…

BMO Lifts Price Target on Healthcare Services Group After Strong Q4 EBITDA; Rating Held at Market Perform

BMO Lifts Price Target on Healthcare Services Group After Strong Q4 EBITDA; Rating Held at Market Perform

BMO Capital increased its price objective on Healthcare Services Group (HCSG) to $22.00 from $20.00 while keeping a Market Perform rating, citing a fourth-quarter adjusted EBITDA beat and improved margins. The firm pointed to a new multi-year revenue growth trajectory and contract-renewal activity that is supporting earnings consistency. The compan…